Washington D.C. – May 12, 2026 – The U.S. Food and Drug Administration (FDA) is navigating a significant leadership transition as Commissioner Martin Makary has resigned, concluding a period marked by considerable upheaval and strategic redirection. Stepping into the acting commissioner role is Kyle Diamantis, formerly the agency’s deputy commissioner for food. This change comes […]